Cellectis Announces the Appointment of Axel-Sven Malkomes&#x

NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company...

Related Keywords

Germany , New York , United States , Paris , France General , France , North Carolina , United Kingdom , Raleigh , French , German , British , Ashleyr Robinson , Margaret Gandolfo , Donalda Bergstrom , Axel Sven Malkomes , Arthur Stril , Donald Bergstrom , Pascalyne Wilson , Head Of Research , Linkedin , Nasdaq , Cellectis The Company Euronext Growth , Merck Kga , University Of Washington , Relay Therapeutics Inc , Barclays , Fred Hutchinson Cancer Research Center , Directors Of The Company Board , Merck Research Laboratories , Securities Exchange Commission , Mergers Acquisitions Business Development , Life Sciences Practice For The British , Youtube , Company Board Of Directors On , Merck Kgaa , Euronext Growth , Chief Executive , Board Observer , Executive Vice President , Relay Therapeutics , Chief Medical Officer , Mersana Therapeutics , Global Head , Experimental Medicine , Oncology Franchise Lead , Sven Malkomes , Chief Financial Officer , Chief Business Officer , Vice Chairman , Managing Director , Life Sciences Practice , Chemicals Investment Banking , European Healthcare , Strategic Planning , Business Development , Nasdaq Global Market , Senior Manager , Lifesci Advisors , Private Securities Litigation Reform Act , Annual Report , Paris Stock Exchange Alcls , Ellectis Inc ,